FDA Issues Guidance To Reduce Risk Of Zika Transmission Through Blood Supply

News outlets report on new FDA guidance recommending individuals not donate blood if they have visited Zika-affected areas, possibly have been exposed to the virus, or have had Zika virus infection in order to reduce the risk of Zika transmission through the blood supply.

CQ HealthBeat: Travelers to Zika Areas Should Defer Blood Donation, FDA Says (Siddons, 2/16).

The Hill: FDA moves to protect blood donations from Zika virus (Sullivan, 2/16).

New York Times: FDA Issues Zika Virus Guidelines for Blood Supply (Saint Louis, 2/16).

Reuters: FDA recommends ban on blood collections from Zika-affected areas (Clarke, 2/16).

Washington Post: FDA: Blood donors at risk for Zika should defer giving blood for 4 weeks (Dennis/Sun, 2/16).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.